Novo Nordisk's pricing tactics while in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of rate gouging, stating the stark distinction concerning U.S. selling prices and people in Europe and copyright.Research of Rybelsus and copyright have shown that equally drugs are successful for assisti